Total Funding
30
5
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
523929
AMO Pharma is a privately held emerging biopharmaceutical company
- Julia Jones: Chief Financial Officer
Michael Snape: Chief Executive Officer & Chief Scientific Officer
About the Company
The company intends to use the funds to advance two clinical-stage pipeline assets targeting rare muscular and central nervous system disorders and to expand the AMO Pharma pipeline through acquisition of additional development-stage products.
